The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The first objective of this study was to characterize the pharmacokinetics and
pharmacodynamics of daptomycin with a daily dose of 12mg/kg in septic shock patient; the
second objective is to identify the optimal dosing scheme for daptomycin among patients with
septic shock and to enhance therapeutic outcomes.